Drug Shortage Report for NAT-QUETIAPINE
Report ID | 226594 |
Drug Identification Number | 02439174 |
Brand name | NAT-QUETIAPINE |
Common or Proper name | Quetiapine |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 150MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-29 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-30 | English | Compare |
v2 | 2024-04-29 | French | Compare |
v1 | 2024-04-29 | English | Compare |
Showing 1 to 3 of 3